Timothy Hoey, SVP, Cancer Biology at OncoMed Pharmaceuticals Inc (OMED), sold 7,500 shares at $22.83 ($171K) on 2015-02-05, disclosed to the SEC on 2015-02-09.
Scheduled sale ($171k) by SVP, Cancer Biology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TNYA | SELL | 2024-02-16 | $27K | — | Filing → |
| TNYA | SELL | 2023-08-29 | $31K | — | Filing → |
| TNYA | SELL | 2023-08-18 | $15K | — | Filing → |